PACTR202108584742856招募中4 期
Molecular Surveillance of Artemisinin Resistance Markers and Impact on Treatment Outcome in Patients with Acute Uncomplicated Plasmodium falciparum Malaria in South-West Nigeria
Amusan Abiodun0 个研究点目标入组 200 人开始时间: 2021年8月16日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Year(s) 至 5 Year(s)（—）
- 性别
- All
入选标准
- •(i) Age 1 to 15 years with symptoms compatible with acute uncomplicated Plasmodium falciparum infection (ii) P. falciparum parasitemia = 2,000 asexual forms of parasite per µL of blood,
- •(iii) Body (axillary) temperature = 37.5°C, or history of fever within one to two days preceding presentation,
- •(iv) Absence of other concomitant illnesses,
- •(v) Absence of any history of antimalarial drug use within 2 weeks prior to presentation,
- •(vi) Written informed consent from parents or guardians of participants.
排除标准
- •(i) severe malaria,
- •(ii) severe malnutrition,
- •(iii) serious underlying diseases (renal, cardiac, or hepatic),
- •(iv) known allergic reaction to study drug.
研究者
相似试验
已完成
不适用
Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of MyanmarDay-3 Positive of ParasitaemiaPrevalence of Drug Resistance Gene MutationNCT02198573Myat Htut Nyunt91
已完成
不适用
Monitoring of Anti-Malarial Drug resistance by real-time quantitative nucleic acid sequence-based amplification and the impact on TRANSmission of Plasmodium falciparumMalariaISRCTN31291803The Netherlands Foundation for the Advancement of Tropical Research (NWO-WOTRO) (The Netherlands)500
尚未招募
不适用
Antimalarial Drug resistance study in West BengalCTRI/2019/08/020575ICMR
招募中
不适用
Elucidation of drug resistance mechanism at metastasis of liver cancer and bile duct canceriver cancer, Bile duct cancerJPRN-UMIN000035090Graduate School of Pharmaceutical Sciences Takasaki University of Health and Welfare120
已完成
不适用
ess Invasive Monitoring of Resistance Mutations in Patients with ALK Rearranged Lung CancerALK rearranged NSCLCJPRN-UMIN000032676Asahikawa Medical University50